Cargando…
Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab
Immunocompromised patients commonly present prolonged viral shedding of the novel coronavirus SARS-CoV-2, detected through reverse transcriptase-polymerase chain reaction (RT-PCR) in nasopharyngeal or oropharyngeal swabs. The detection and estimation of the viral load in patients with COVID-19 is of...
Autores principales: | Kintrilis, Nikos, Gkinos, Charilaos P, Galinos, Iosif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840416/ https://www.ncbi.nlm.nih.gov/pubmed/36654638 http://dx.doi.org/10.7759/cureus.32523 |
Ejemplares similares
-
Elevated Liver Enzymes in an Adult Male With Anorexia Nervosa: A Case Report
por: Kintrilis, Nikolaos
Publicado: (2022) -
Viral Shedding and Persistence of Anosmia and Ageusia in an Asymptomatic SARS-CoV-2 Infection
por: Kintrilis, Nikolaos
Publicado: (2023) -
Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review
por: Vivekanandan, Govinathan, et al.
Publicado: (2021) -
PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
por: WEBER, ANDREW, et al.
Publicado: (2021) -
A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
por: Kandah, Emad, et al.
Publicado: (2021)